Both in Biotechnology
Neurocrine Biosciences vs Vaxcyte
Over the past year NBIX returned +2.9% and PCVX returned +41.9%; their daily moves had a correlation of 0.22.
NBIX +2.9% PCVX +41.9%Growth of $1, one year, split-adjusted
| Metric | NBIX | PCVX |
|---|---|---|
| Price | $146.09 | $60.79 |
| Market cap | $14.85B | $9.57B |
| Today | −0.01% | −2.00% |
| 1 month | +2.0% | +7.6% |
| 6 months | +9.0% | +3.9% |
| Year to date | +3.0% | +31.8% |
| 1 year | +5.8% | +35.8% |
| Revenue growth (YoY) | +39.5% | — |
| Gross margin | 97.6% | — |
| Net margin | 15.1% | — |
| P/E (TTM) | 21.0× | — |
| Price / sales | 4.4× | — |
| Net cash | $389.8M | $1.49B |
| Dividend yield | — | — |
| Volatility (60d) | 25.9% | 70.6% |
| Short % of float | 6.6% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).